San Francisco Biotechnology Network | Bay Area Life Science News, Jobs & Events

  • Home
  • About
  • News
    • SFBN Trending & Featured News & Jobs
  • SFBN Jobs
    • Submit a Job
  • Subscribe
  • Contact
News Ticker
  • [ December 6, 2023 ] Research Associate II/Sr. Research Associate – Purification – Circle Pharma – South San Francisco, CA San Francisco Biotech Jobs
  • [ December 6, 2023 ] Antibody drugmaker IGM to cut 20% of jobs News
  • [ December 6, 2023 ] Critical Infrastructure Still at High Risk: Forescout Research Spotlights 21 New Vulnerabilities News
  • [ December 6, 2023 ] Utilities Mechanic – Mentor Technical Group – San Francisco, CA San Francisco Biotech Jobs
  • [ December 6, 2023 ] Senior Scientist – Protein engineering and structural biochemistry – Alector – South San Francisco, CA San Francisco Biotech Jobs
HomeBiotechnology

Biotechnology

No Picture
News

STAT+: ASCO showcased the payoff for new cancer medicines: longer lives

June 7, 2023 San Francisco Biotechnology Network News Comments Off on STAT+: ASCO showcased the payoff for new cancer medicines: longer lives

As new cancer drugs arrive, regulators and doctors still struggle with when to use drugs based on earlier data and when to wait for survival data. #ASCO23 […]

No Picture
News

STAT+: Gilead’s CAR-T therapy prolongs survival in key blood cancer trial

June 5, 2023 San Francisco Biotechnology Network News Comments Off on STAT+: Gilead’s CAR-T therapy prolongs survival in key blood cancer trial

Proving a meaningful survival benefit for patients with a type of blood cancer represents another milestone for CAR-T therapy. #ASCO23 […]

No Picture
News

‘Robbing Peter to pay Paul’: Obesity experts debate risks of new weight loss drugs

May 8, 2023 San Francisco Biotechnology Network News Comments Off on ‘Robbing Peter to pay Paul’: Obesity experts debate risks of new weight loss drugs

Amid rising demand for drugs like Wegovy and Ozempic that can lead to significant weight loss, some obesity experts are concerned about the drugs’ costs — both to patients’ finances… […]

No Picture
News

STAT+: Doudna talks cost, access issues looming over first CRISPR therapy

May 5, 2023 San Francisco Biotechnology Network News Comments Off on STAT+: Doudna talks cost, access issues looming over first CRISPR therapy

“How do we make sure that a technology like CRISPR — you know, no offense intended — is not just going to make a few people rich, but it’s going… […]

No Picture
News

STAT+: Gilead foresees more growth in its HIV drugs

May 4, 2023 San Francisco Biotechnology Network News Comments Off on STAT+: Gilead foresees more growth in its HIV drugs

Gilead’s CEO believes the foundation of the company will continue to be its HIV franchise, particularly PrEP. #STATBreakthrough […]

No Picture
News

Listen: Lilly’s Alzheimer’s success, a milestone FDA approval, & Moderna’s shrinking business

May 4, 2023 San Francisco Biotechnology Network News Comments Off on Listen: Lilly’s Alzheimer’s success, a milestone FDA approval, & Moderna’s shrinking business

What’s the future of Alzheimer’s disease treatment? How do you pivot from a pandemic? And how successful can Wegovy get? Find out on the new episode of “The Readout LOUD.” […]

No Picture
News

STAT+: CAR-T research is flourishing but is hampered by outdated precautions, experts say

May 4, 2023 San Francisco Biotechnology Network News Comments Off on STAT+: CAR-T research is flourishing but is hampered by outdated precautions, experts say

A gathering of experts in CAR-T cancer therapy at #STAT breakthrough express optimism about making therapy faster and more accessible, while also raising concerns about falling behind China. […]

No Picture
News

For Eli Lilly’s head scientist, Alzheimer’s results cap a 25-year scientific quest

May 3, 2023 San Francisco Biotechnology Network News Comments Off on For Eli Lilly’s head scientist, Alzheimer’s results cap a 25-year scientific quest

“Probably any words I use to describe my emotions at seeing this data will understate it,” said Daniel Skovronsky, Eli Lilly’s head scientist. […]

No Picture
News

STAT+: A biotech upstart takes on cancer by crowdsourcing the immune system’s natural killers

April 11, 2023 San Francisco Biotechnology Network News Comments Off on STAT+: A biotech upstart takes on cancer by crowdsourcing the immune system’s natural killers

ImmuneBridge, a San Francisco-based startup, is developing cancer immunotherapies based on so-called natural killer cells. […]

No Picture
News

STAT+: ‘It was my call’: Stanford president defends decision not to correct key paper in misconduct investigation

April 11, 2023 San Francisco Biotechnology Network News Comments Off on STAT+: ‘It was my call’: Stanford president defends decision not to correct key paper in misconduct investigation

Stanford president Marc Tessier-Lavigne took responsibility for the decision not to correct or retract a paper at the heart of scientific-misconduct allegations. […]

Posts navigation

1 2 … 4 »
POST A JOB

Featured Jobs

Follow Us On Twitter

Tweets by @sdbn

Networking & Associations

  • AWIS-SF
  • Bay Area Society for Neuroscience
  • BioScience Forum
  • California Life Sciences Association
  • Meetup: Bay Area Life Tech
  • Meetup: East Bay Bio Network
  • Meetup: San Francisco Biotechnology Meetup
  • Meetup: San Francisco Life Science Professionals
  • Parenteral Drug Association West Coast Chapter
  • SynBioBeta
  • Women in Bio San Francisco

Copyright © 2023 Biotech Networks, LLC

Get Biotech Networks Briefs in Your Inbox: Trending News & Featured Jobs